PBS Calendars

PBS related activities surrounding the PBAC meeting cycles

Sponsors who are concerned they cannot meet the deadline to list a new brand that will trigger a first new brand price reduction, are encouraged to email PBSPricing@health.gov.au to discuss available options.

If you are considering applying to have a drug listed on the PBS, it is recommended that you contact the Office of Health Technology Assessment (OHTA) to discuss the  listing steps. If you are unsure of the most appropriate person to contact, the Industry Liaison Officer will be able to assist.

All contact details are available from the PBS contacts page.

PBAC Cycle Timeframe for 2026 - 2027

PBAC Cycle Timeframe for 2026 - 2027 (PDF 339KB) - (Word 64KB)

MEETING

2026/2

8-10 July

2026/3

4-6 November

2027/1

10-12 March

2027/2

7-9 July

2027/3

3-5 November

Activity

Wk

Date

Wk

Date

Wk

Date

Wk

Date

Wk

Date

Deadline for Notice of Intent for integrated co-dependent submissions (Wednesday 5pm AEST)

-8

14 Jan 2026

-8

13 May 2026

-8

9 Sep 2026

-8

13 Jan 2027

-8

12 May 2027

Requested date for Notice of Intent for Category 1-4 and Committee Secretariat submissions and Standard Re-entry resubmissions (Wednesday 5pm AEST)

 

*NOIs will continue to be accepted up to 20 business days before the submission due day

-8

14 Jan 2026

-8

13 May 2026

-8

9 Sep 2026

-8

13 Jan 2027

-8

12 May 2027

 

-7

 

-7

 

-7

 

-7

 

-7

 

 

-6

 

-6

 

-6

 

-6

 

-6

 

 

-5

 

-5

 

-5

 

-5

 

-5

 

Deadline for integrated co-dependent submissions (Wednesday 5pm AEST)

-4

11 Feb 2026

-4

10 June 2026

-4

7 Oct 2026

-4

10 Feb 2027

-4

9 Jun 2027

 

-3

 

-3

 

-3

 

-3

 

-3

 

 

-2

 

-2

 

-2

 

-2

 

-2

 

 

-1

 

-1

 

-1

 

-1

 

-1

 

Deadline for Category 1 to 4 and Committee Secretariat submissions; and Facilitated Resolution Pathway and Standard Re-entry Pathway resubmissions (Wednesday 5pm AEST)

0

11 Mar 2026

0

8 Jul 2026

0

4 Nov 2026

0

10 Mar 2027

0

7 Jul 2027

 

1

 

1

 

1

 

1

 

1

 

Publication of the main Agenda on web (Wednesday)

2

25 Mar 2026

2

22 Jul 2026

2

18 Nov 2026

2

24 Mar 2027

2

21 Jul 2027

Consumer Consultation opens

(Wednesday)

2

25 Mar 2026

2

22 Jul 2026

2

18 Nov 2026

2

24 Mar 2027

2

21 Jul 2027

 

3

 

3

 

3

 

3

 

3

 

 

4

 

4

 

4

 

4

 

4

 

Deadline for pre-submission meeting requests to meet 8 week cut-off

5

17 Apr 2026

5

14 Aug 2026

5

11 Dec 2026

5

16 Apr 2027

5

13 Aug 2027

Deadline for Notice of Intent for Re-entry Pathway resubmissions (Friday 5pm AEST)

6

24 Apr 2026

6

21 Aug 2026

6

18 Dec 2026

6

23 Apr 2027

6

20 Aug 2027

Deadline for Early Re-entry Pathway resubmissions (Friday 5pm AEST)

7

1 May 2026

7

28 Aug 2026

7

23 Dec 2026

(Dept Shutdown 24 Dec – 3 Jan)

7

30 Apr 2027

7

27 Aug 2027

Publication of the updated Agenda on web

(Friday)

8

8 May 2026

8

4 Sep 2026

8

8 Jan 2027

8

7 May 2027

8

3 Sep 2027

Pre-submission meetings: 8 week cut-off

9

11-15 May 2026

9

7-11 Sep 2026

9

11-15 Jan 2027

9

10-14 May 2027

9

6-10 Sep 2027

Consumer Consultation closes (Wednesday)

10

20 May 2026

10

16 Sept 2026

10

20 Jan 2027

10

19 May 2027

10

15 Sep 2027

Submission commentaries to Applicants (Wednesday)

10

20 May 2026

10

16 Sep 2026

10

20 Jan 2027

10

19 May 2027

10

15 Sep 2027

Applicants Pre-Subcommittee Responses (PSCRs) to PBAC Secretariat (midday Wednesday)

11

27 May 2026

11

23 Sep 2026

11

27 Jan 2027

11

26 May 2027

11

22 Sep 2027

Deadline for item delist submissions (Monday 5pm AEST)

12

N/A

12

N/A

12

1 Feb 2027

12

31 May 2027

12

27 Sept 2027

DUSC and ESC meetings including joint meeting (Wednesday-Friday)

12

3-5 Jun 2026

12

30 Sep – 2 Oct

12

3-5 Feb 2027

12

2-4 Jun 2027

12

29 Sep-1 Oct 2027

 

13

 

13

 

13

 

13

 

13

 

Deadline for item delist submissions (Monday 5pm AEST)

14

15 Jun 2026

14

12 Oct 2026

14

N/A

14

N/A

14

N/A

Submission overviews, ESC, DUSC & ATAGI (vaccine submissions) advice & summary of consumer inputs to Applicants (Wednesday)

15

24 Jun 2026

15

21 Oct 2026

15

25 Feb 2027

15

23 Jun 2027

15

20 Oct 2027

Applicants send Pre-PBAC Responses to PBAC Secretariat (by midday Wednesday)

16

1 Jul 2026

16

28 Oct 2026

16

3 Mar 2027

16

30 Jun 2027

16

27 Oct 2027

PBAC MEETING (Wednesday-Friday)

17

8-10 July 2026

17

4-6 Nov 2026

17

10-12 March 2027

17

7-9 Jul 2027

17

3-5 Nov 2027

POST PBAC PROCEDURES:

18

 

18

 

18

 

18

 

18

 

 

19

 

19

 

19

 

19

 

19

 

Ratified Minutes (positive outcomes) to Applicants (Friday)

20

31 Jul 2026

20

27 Nov 2026

20

1 Apr 2027

20

30 Jul 2027

20

26 Nov 2027

Publication of the PBAC December Intracycle Agenda on web (Friday)

21

N/A

21

4 Dec 2026

21

N/A

21

N/A

21

3 Dec 2027

PBAC DECEMBER INTRACYCLE MEETING (Wednesday)

22

N/A

22

9 Dec 2026

22

N/A

22

N/A

22

8 Dec 2027

Ratified Minutes (all other outcomes) to Applicants (Friday)

22

14 Aug 2026

22

11 Dec 2026

22

16 Apr 2027

22

13 Aug 2027

22

10 Dec 2027

Post-PBAC meetings with PBAC Chair (Tue-Wed)

23

18-19 Aug 2026

23

15-16 Dec 2026

23

20-21 Apr 2027

23

17-18 Aug 2027

23

14-15 Dec 2027

Posting of outcomes on website following Applicants comments (Friday); and deadline for Notice of Intent for Early Resolution Pathway resubmissions (Friday 5pm AEST)

23

21 Aug 2026

23

18 Dec 2026 (24 Dec – 3 Jan Dept shutdown)

23

23 Apr 2027

23

20 Aug 2027

23

17 Dec 2027

Deadline for Independent Review requests for reconsideration at the meeting following the next meeting (Friday); and

deadline for Early Resolution Pathway resubmissions (Friday 5pm AEST)

24

28 Aug 2026

24

23 Dec 2026

(24 Dec – 3 Jan Dept shutdown)

24

30 Apr 2027

24

27 Aug 2027

24

23 Dec 2027
(24 Dec – 3 Jan Dept shutdown)

Publication of the PBAC Intracycle Agenda on web (Friday) (except December meeting)

24

28 Aug 2026

24

N/A

24

30 Apr 2027

24

27 Aug 2027

24

N/A

PBAC INTRACYCLE MEETING (Friday) (except December meeting)

25

4 Sep 2026

25

N/A

25

7 May 2027

25

3 Sep 2027

25

N/A

PBAC December Intracycle ratified minutes (positive outcomes) to Applicants (Friday)

25

N/A

25

8 Jan 2027

25

N/A

25

N/A

25

7 Jan 2028

 

26

 

26

 

26

 

26

 

26

 

Draft Public Summary Documents (PSDs) to Applicants (Friday)

27

18 Sep 2026

27

N/A

27

21 May 2027

27

17 Sep 2027

27

N/A

PBAC December Intracycle ratified minutes (all other outcomes) to Applicants (Friday)

27

N/A

27

22 Jan 2027

27

N/A

27

N/A

27

21 Jan 2028

PBAC December Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed)

28

N/A

28

27-28 Jan 2027

(Australia Day 26 Jan)

28

N/A

28

N/A

28

24-25 Jan 2028 (Australia Day 26 Jan)

PBAC Intracycle ratified minutes (positive outcomes) to Applicants (Friday) (except December meeting)

28

25 Sep 2026

28

N/A

28

28 May 2027

28

24 Sep 2027

28

N/A

PBAC December Intracycle posting of outcomes on website (Friday)

28

N/A

28

29 Jan 2027

28

N/A

28

N/A

28

28 Jan 2028

 

29

 

29

 

29

 

29

 

29

 

PBAC Intracycle ratified minutes (all other outcomes) to Applicants (Friday) (except December meeting)

30

9 Oct 2026

30

12 Feb 2027

30

11 June 2027

30

8 Oct 2027

30

11 Feb 2028

PBAC Intracycle Post-PBAC meetings with PBAC Chair (Tue-Wed) (except December meeting)

31

13-14 Oct 2026

31

N/A

31

15-16 June 2027

31

12-13 Oct 2027

31

N/A

Final PSDs to Applicants (Friday)

 

31

16 Oct 2026

31

19 Feb 2027

31

18 June 2027

31

15 Oct 2027

31

18 Feb 2028

PBAC Intracycle posting of outcomes on website (except December meeting)

31

16 Oct 2026

31

N/A

31

18 June 2027

31

15 Oct 2027

31

N/A

Draft PBAC December Intracycle PSDs to Applicants (Friday)

32

N/A

32

26 Feb 2027

32

N/A

32

N/A

32

25 Feb 2028

 

33

 

33

 

33

 

33

 

33

 

 

34

 

34

 

34

 

34

 

34

 

PSDs published on website (Friday)

35

13 Nov 2026

35

19 Mar 2027

35

16 July 2027

35

12 Nov 2027

35

17 Mar 2028

Draft PBAC Intracycle PSDs to Applicants (Friday) (except December meeting)

35

13 Nov 2026

35

N/A

35

16 July 2027

35

12 Nov 2027

35

N/A

Final PBAC December Intracycle PSDs to Applicants (Friday)

36

N/A

36

25 Mar 2027

(26 Mar Good Friday)

36

N/A

36

N/A

36

24 Mar 2028

 

37

 

37

 

37

 

37

 

37

 

 

38

 

38

 

38

 

38

 

38

 

Final PBAC Intracycle PSDs to Applicants (Friday) (except December meeting)

39

11 Dec 2026

39

N/A

39

13 Aug 2027

39

10 Dec 2027

39

N/A

PBAC December Intracycle PSDs published on website (Friday)

40

N/A

40

23 Apr 2027

40

N/A

40

N/A

40

21 Apr 2028

 

41

 

41

 

41

 

41

 

41

 

 

42

 

42

 

42

 

42

 

42

 

PBAC Intracycle PSDs published on website (Friday) (except December meeting)

43

15 Jan 2027

43

N/A

43

10 Sep 2027

43

14 Jan 2028

43

N/A

ATAGI = Australian Technical Advisory Group on Immunisation

DUSC = Drug Utilisation Sub Committee    
ESC = Economics Sub Committee
PBAC = Pharmaceutical Benefits Advisory Committee
PSDs = Public Summary Documents
“responsible persons” = legal wording requirement for terminology – previously known as sponsors
TBC = To be Confirmed
*  These dates may vary based on the number of submissions received

Pre-submission meetings

Sponsors may apply for a pre-submission meeting with the Department at any time. Pre-submission meetings are held throughout the entire PBAC meeting cycle, subject to availability. Please refer to the PBS Calendar above in relation to cut-off dates for applications submitting to the next major submission deadline. Additional information on procedures and links to application and briefing paper templates are outlined in the Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme.

If the item to be discussed is a co-dependent technology, sponsors should separately contact the Health Technology Assessment (HTA) team (hta@health.gov.au) to discuss the required MSAC processes.

Health technologies are co-dependent if their use needs to be combined (either sequentially or simultaneously) to achieve or enhance the intended clinical effect of either technology.  For example, a drug/test combination where a new medicine seeking listing on the PBS may have a related pathology test that helps to determine the population group for that medicine.

If you have any questions regarding pre-submission meetings, please contact the Pre-submission Meetings Team via email (PBACpresubmissionmeetings@health.gov.au).


Last updated
1 October 2026